The current IMUN market cap is 7.64M. The company's latest EPS is USD -0.0430 and P/E is -1.16.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 114k | 0 | 0 | 0 | 0 |
Operating Income | -4.46M | -2.84M | -887k | -739k | -1.16M |
Net Income | -8.18M | -3.4M | 1.59M | 3.59M | -3.54M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 92k | 6k | 10k | 3.14M | 964k |
Total Liabilities | 11.34M | 13.69M | 11.68M | 11.09M | 3.48M |
Total Equity | -11.25M | -13.69M | -11.67M | -7.95M | -2.51M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -1.37M | -1,000 | -192k | -232k | -582k |
Investing | -2k | N/A | N/A | N/A | -500k |
Financing | 1.36M | N/A | 197k | 716k | 738k |
Market Cap | 7.64M |
Price to Earnings Ratio | -1.16 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 27.78 |
Price to Book Ratio | -1.64 |
Dividend Yield | - |
Shares Outstanding | 82.2M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -84.50% |
52 Week High | 0.90 |
52 Week Low | 0.06675 |
Spread (Intraday) | 0.03 (28%) |
Company Name | Immune Therapeutics Inc (PK) |
Address |
37 north orange ave, suite 607 orlando, florida 32801 |
Website | https://www.immunetherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.